Loading search results
Design and Evaluation of the Effectiveness of a Digital Health Intervention to Improve Health Care and Outcomes for Cancer Patients
Sponsor study identifier
interventional
410
1 country
3
Study Start
March 5, 2024
Actual (reported)Primary Completion
October 10, 2025
Actual (reported)Study Completion
October 10, 2025
Actual (reported)Background: Nearly 30,000 Mexican women develop breast cancer annually. These patients frequently present multiple unmet supportive care needs. In high-income settings, incorporating electronic patient-reported outcomes (ePROs) into cancer care has demonstrated potential for increasing patient-centred care and reducing unmet needs. No such ePRO interventions have been implemented in Mexico. The objectives of this study are (I) to design a two-component intervention for monitoring ePROs among breast cancer patients using a responsive digital application and proactive follow-up by nurses, (II) to perform intervention pilot testing of the study materials, and (III) to conduct the clinical trial to assess usability and effectiveness of the intervention. Methods. The investigators designed a two-component intervention for women receiving breast cancer treatment: a responsive web application for monitoring ePROs and clinical algorithms guiding proactive follow-up by nurses. The investigators will conduct a pilot test of the intervention with 50 breast cancer patients for six weeks to assess the feasibility and inform intervention adaptations. After that, the investigators will conduct a parallel arm randomized controlled trial assigning 205 patients each to intervention and control in one of Mexico's largest public oncology hospitals. The intervention will be provided for six months, with additional three months of post-intervention observation. The control group will receive usual healthcare and a list of information sources on relevant breast cancer topics. Women diagnosed with stages I, II, or III breast cancer who initiate chemo and/or radiotherapy will be invited to participate. The study outcomes will include supportive care needs, quality of life, use of emergency services and unscheduled hospitalizations, the usability of the ePRO App, and adherence to the intervention. Information on the outcomes will be obtained through web-based self-administered questionnaires collected at baseline, 1, 3, 6, and 9 months.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 10, 2025
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 21, 2023
Actual (reported)June 29, 2023
Actual (reported)March 5, 2024
Actual (reported)October 10, 2025
Actual (reported)October 10, 2025
Actual (reported)Health systems and information supportive care needs
Change from baseline in health systems and information supportive care needs at 1, 3, 6 and 9 months after the intervention commencement, which will be measured with the Supportive Care Needs Survey Short Form-34 (SCNS SF-34) questionnaire validated in Mexico.
At 1, 3, 6 and 9 months after intervention commencement
Global quality of life
At 1, 3, 6 and 9 months after intervention commencement
Breast symptoms
At 1, 3, 6 and 9 months after intervention commencement
Use of emergency services
At 1, 3, 6 and 9 months after intervention commencement
Use of the responsive ePRO App in the intervention group
At 1, 3 and 6 months after intervention commencement
Unscheduled hospitalizations
At 1, 3, 6 and 9 months after intervention commencement
The intervention group will be given access to the ePRO application and proactive clinical care, including study nurses responding to ePROs and weekly health information videos for six months.
Participants of the control group will be provided with a list of electronic links to videos on breast cancer-relevant topics on the websites of recognised cancer associations and health institutions.
The investigators defined ePRO intervention as a weekly register of breast cancer patients' symptoms and supportive care needs using the study ePRO App combined with proactive follow-up by nurses guided by predefined clinical algorithms and a weekly cellphone message providing an educational video from a recognised cancer association or health institution. The intervention will be provided for six months with additional three months of post-intervention observation.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
UMAE Hospital de Gineco-Obstetricia No.3 "Dr. Víctor Manuel Espinoza de los Reyes Sánchez" CMN La Raza.
Mexico City, Mexico City, 02990, Mexico
Hospital de Oncología del Centro Médico Nacional Siglo XXI
Mexico City, Mexico City, 06720, Mexico
UMAE Hospital de Especialidades CMN "Gral. de Div. Manuel Ávila Camacho"
Puebla City, 72089, Mexico
Contreras-Sanchez SE, Doubova SV, Grajales-Alvarez R, Villalobos-Valencia R, Dip-Borunda AK, Nunez-Cerrillo JG, Huerta-Lopez AD, Montiel-Jarquin AJ, Garcia-Galicia A, Talamantes-Gomez EI, Sanchez-Reyes RI, Aguirre-Gomez J, Gonzalez-Santiesteban S, Molina-Perez CJ, Leslie HH. Effectiveness of a digital health intervention on the supportive care needs and quality of life in Mexican patients with breast cancer: a randomized clinical trial. BMC Cancer. 2026 Feb 16;26(1):391. doi: 10.1186/s12885-026-15724-w.
Contreras Sanchez SE, Doubova SV, Martinez Vega IP, Grajales Alvarez R, Villalobos Valencia R, Dip Borunda AK, Lio Mondragon L, Martinez Pineda WJ, Nunez Cerrillo JG, Huerta Lopez AD, Zalapa Velazquez R, Mendoza Ortiz V, Vazquez Zamora VJ, Montiel Jarquin AJ, Garcia Galicia A, Talamantes Gomez EI, Sanchez Reyes R, Aguirre Gomez J, Ayala Anzures ME, Zapata Tarres M, Monroy A, Leslie HH. Addressing the unmet needs of women with breast cancer in Mexico: a non-randomised pilot study of the digital ePRO intervention. BMJ Open. 2024 Jun 21;14(6):e087240. doi: 10.1136/bmjopen-2024-087240.
Svetlana V. Doubova, MD. DSc.
Instituto Mexicano del Seguro Social
410 participants (actual enrollment reported by the registry).
First Submitted
June 21, 2023
First Posted
June 29, 2023
Study Start
Contact the study team to confirm eligibility.
Contreras Sanchez SE, Doubova SV, Grajales Alvarez R, Dip Borunda AK, Martinez Pineda WJ, Nunez Cerrillo JG, Silva Bravo F, Zalapa Velazquez R, Gutierrez De la Barrera M, Leslie HH. Design and evaluation of a digital health intervention with proactive follow-up by nurses to improve healthcare and outcomes for patients with breast cancer in Mexico: protocol for a randomised clinical trial. BMJ Open. 2023 Nov 6;13(11):e077322. doi: 10.1136/bmjopen-2023-077322.
March 5, 2024
Actual (reported)Primary Completion
October 10, 2025
Actual (reported)Study Completion
October 10, 2025
Actual (reported)Last Updated
October 22, 2026
Record last verified: 2026-10
De-identified study variables will be available.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: